AU2001275244A1 - Starter kit for low dose oral contraceptives - Google Patents

Starter kit for low dose oral contraceptives

Info

Publication number
AU2001275244A1
AU2001275244A1 AU2001275244A AU7524401A AU2001275244A1 AU 2001275244 A1 AU2001275244 A1 AU 2001275244A1 AU 2001275244 A AU2001275244 A AU 2001275244A AU 7524401 A AU7524401 A AU 7524401A AU 2001275244 A1 AU2001275244 A1 AU 2001275244A1
Authority
AU
Australia
Prior art keywords
low dose
oral contraceptives
dose oral
starter kit
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001275244A
Other languages
English (en)
Inventor
Gary S Grubb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU2001275244A1 publication Critical patent/AU2001275244A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
AU2001275244A 2000-06-08 2001-06-05 Starter kit for low dose oral contraceptives Abandoned AU2001275244A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21031000P 2000-06-08 2000-06-08
US60/210,310 2000-06-08
PCT/US2001/018142 WO2001093848A2 (en) 2000-06-08 2001-06-05 Starter kit for low dose oral contraceptives

Publications (1)

Publication Number Publication Date
AU2001275244A1 true AU2001275244A1 (en) 2001-12-17

Family

ID=22782382

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001275244A Abandoned AU2001275244A1 (en) 2000-06-08 2001-06-05 Starter kit for low dose oral contraceptives

Country Status (14)

Country Link
US (1) US7297688B2 (es)
EP (1) EP1286666B1 (es)
JP (1) JP2003535127A (es)
CN (1) CN1313095C (es)
AT (1) ATE286726T1 (es)
AU (1) AU2001275244A1 (es)
BR (1) BR0111509A (es)
CA (1) CA2410993A1 (es)
DE (1) DE60108377T2 (es)
ES (1) ES2236243T3 (es)
MX (1) MXPA02012108A (es)
PT (1) PT1286666E (es)
SI (1) SI1286666T1 (es)
WO (1) WO2001093848A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060281723A1 (en) * 1999-04-16 2006-12-14 Kafrissen Michael E Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
EP1624848A4 (en) * 2003-05-02 2009-02-25 Duramed Pharmaceuticals Inc METHOD FOR HORMONY TREATMENT WITH CONTRAZEPTVA SCHEMATES WITH EXTENDED CYCLE
NZ585546A (en) * 2003-07-16 2011-10-28 Teva Womens Health Inc Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
DE102004026671A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
AR051931A1 (es) * 2004-10-07 2007-02-21 Duramed Pharmaceuticals Inc Metodos de tratamiento hormonal que utilizan regimenes de ciclos extendidos con dosis ascendentes
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US7704984B2 (en) * 2005-04-22 2010-04-27 Warner Chilcott Company, Llc Extended estrogen dosing contraceptive regimen
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530839A (en) 1983-09-26 1985-07-23 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
DE19525017A1 (de) 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE19540253C2 (de) 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
WO1997041870A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
JP2000515888A (ja) 1996-07-26 2000-11-28 アメリカン・ホーム・プロダクツ・コーポレイション 経口避妊薬
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
DE19739916C2 (de) 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
TR200002995T2 (tr) 1998-04-17 2001-01-22 Ortho-Mcneil Pharmaceutical,Inc. Folik asit ihtiva eden farmasötik bileşimler, bununla ilgili yöntemler ve uygulama sistemleri

Also Published As

Publication number Publication date
BR0111509A (pt) 2003-07-08
DE60108377T2 (de) 2006-04-06
US7297688B2 (en) 2007-11-20
CN1436081A (zh) 2003-08-13
JP2003535127A (ja) 2003-11-25
CN1313095C (zh) 2007-05-02
ATE286726T1 (de) 2005-01-15
DE60108377D1 (de) 2005-02-17
WO2001093848A3 (en) 2003-01-09
MXPA02012108A (es) 2003-04-25
WO2001093848A2 (en) 2001-12-13
CA2410993A1 (en) 2001-12-13
PT1286666E (pt) 2005-05-31
US20020010167A1 (en) 2002-01-24
EP1286666B1 (en) 2005-01-12
ES2236243T3 (es) 2005-07-16
EP1286666A2 (en) 2003-03-05
SI1286666T1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
IL148211A0 (en) Selecting the delivery mechanism of an urgent message
HK1154485A1 (zh) 防止懷孕的口服避孕藥
AU7174101A (en) Pharmaceutical compositions of estrogenic agents
WO2002040495A3 (en) Improved sucralose composition and process for the crystallization thereof
GEP20063882B (en) Dosage regimen and pharmaceutical composition for emergency contraception
MXPA02012897A (es) Combinaciones de bisfosfonatos, agentes estrigenicos y opcionalmente estrogenos.
AU2002224198A1 (en) Fragrance composition comprising cyclohexadecanone
AU2001275244A1 (en) Starter kit for low dose oral contraceptives
MXPA02012896A (es) Combinaciones de estatinas, agentes estrogenicos y opcionalmente estrogenos.
CA2415197A1 (en) Cast wheel rim
WO2001078682A3 (en) Sustained release drug compositions
GB0007760D0 (en) Composition
EP1275394A3 (en) Ultra low dose oral contraceptives with sustained efficacy that induces amenorrhea
AU2001262793A1 (en) Photoresist remover composition
AU2002218278A1 (en) Water-selective cementing composition
GB0013350D0 (en) End of message markers
GB0108903D0 (en) Novel crystalline forms of a factor Xa inhibitor
AU2001215831A1 (en) Fragrance compositions
WO2003034981A3 (en) Prevention of recurrent viral disease
AU2001252770A1 (en) Electron-beam lithography
AU2002210683A1 (en) Identification of hla-dr restricted hcv epitopes
ZA200300417B (en) 16alpha-methyl or ethyl substituted estrogens.
DE60212130D1 (en) Carvedilolpolymorph
AU2001268689A1 (en) Alpha-arylated cinnamic esters and 1,4-bis(alpha-carboxyl-beta-styryl)benzene esters as uv-blocking agents
ZA200309578B (en) Male contraceptives.